{"transactions":[{"id":1784232,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":109838,"kind":"person","name":"Gallagher Patrick Stephen","position":1,"cik":"0001932215","reported_name":"Gallagher Patrick Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-09-11T21:34:32.000Z","date":"2023-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9383,"price":1.5,"value":14074.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":34130,"source":{"system":"sec-edgar","filing":"0001209191-23-048968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123048968/doc4.xml","form_type":"4"}},{"id":1936181,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":109838,"kind":"person","name":"Gallagher Patrick Stephen","position":1,"cik":"0001932215","reported_name":"Gallagher Patrick Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-29T21:13:45.000Z","date":"2023-02-15","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 15, 2024, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":60000,"derivative":{"exercise_price":1.43,"expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-23-021540","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123021540/doc4a.xml","form_type":"4/A","original_submission_date":"2023-02-17"}},{"id":1936180,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":109838,"kind":"person","name":"Gallagher Patrick Stephen","position":1,"cik":"0001932215","reported_name":"Gallagher Patrick Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-03-29T21:13:45.000Z","date":"2023-02-15","kind":"grant","planned":false,"acquired":true,"shares":14200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares represent RSUs. Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in four equal annual installments on each of February 15, 2024, February 15, 2025, February 15, 2026 and February 15, 2027, subject to the Reporting Person's continuous service with the Issuer as of each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amendment is being filed solely to correct the number of shares beneficially owned, which the original filing overreported by two shares."}],"balance_after":43513,"source":{"system":"sec-edgar","filing":"0001209191-23-021540","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123021540/doc4a.xml","form_type":"4/A","original_submission_date":"2023-02-17"}},{"id":1936179,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":109838,"kind":"person","name":"Gallagher Patrick Stephen","position":1,"cik":"0001932215","reported_name":"Gallagher Patrick Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-03-29T21:13:45.000Z","date":"2023-02-15","kind":"grant","planned":false,"acquired":true,"shares":29313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This amendment is being filed solely to correct the number of shares beneficially owned, which the original filing overreported by two shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares represent restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs are fully vested."}],"balance_after":29313,"source":{"system":"sec-edgar","filing":"0001209191-23-021540","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123021540/doc4a.xml","form_type":"4/A","original_submission_date":"2023-02-17"}},{"id":2009498,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":109838,"kind":"person","name":"Gallagher Patrick Stephen","position":1,"cik":"0001932215","reported_name":"Gallagher Patrick Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-17T22:01:28.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 15, 2024, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":60000,"derivative":{"exercise_price":1.43,"expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-23-010734","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123010734/doc4.xml","form_type":"4"}},{"id":2009497,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":109838,"kind":"person","name":"Gallagher Patrick Stephen","position":1,"cik":"0001932215","reported_name":"Gallagher Patrick Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-02-17T22:01:28.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":14200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares represent RSUs. Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in four equal annual installments on each of February 15, 2024, February 15, 2025, February 15, 2026 and February 15, 2027, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":43515,"source":{"system":"sec-edgar","filing":"0001209191-23-010734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123010734/doc4.xml","form_type":"4"}},{"id":2009496,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":109838,"kind":"person","name":"Gallagher Patrick Stephen","position":1,"cik":"0001932215","reported_name":"Gallagher Patrick Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-02-17T22:01:28.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":29313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs are fully vested."}],"balance_after":29313,"source":{"system":"sec-edgar","filing":"0001209191-23-010734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123010734/doc4.xml","form_type":"4"}},{"id":2246164,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":109838,"kind":"person","name":"Gallagher Patrick Stephen","position":1,"cik":"0001932215","reported_name":"Gallagher Patrick Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T20:20:13.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable as to 25% of the shares underlying the option on June 1, 2023, and the remaining 75% of the shares underlying the Option shall vest and become exercisable in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.91,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-22-034040","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919122034040/doc4.xml","form_type":"4"}}]}